Abbott just received FDA approval for the Absorb coronary heart stent, the first and only fully resorbable stent available in the U.S. We’re kind of surprised the company is calling it what it is and isn’t pushing the new term “scaffold” on us. Nevertheless, while it is novel, the device isn’t exactly a new product, having been approved in the EU already six years ago, available in over 100 countries, and having gone through years of study.
The federal Medicare agency has endorsed the use of unique identification numbers in billing records for medical devices, a move safety advocates say is crucial in helping detect malfunctions in devices such as heart defibrillators, […]
New hip replacement implant system builds on ConforMIS’s customized knee replacement technology and positions Company to expand in global orthopedics market […]
An entry published in the International Journal of Cardiology explored the many recent applications of 3D printing technology in the treatment of heart-related diseases and surgeries. The article, published earlier this month, highlighted several case studies […]